Olivia was deeply committed to advancing research for metastatic breast cancer (MBC) both through her own participation in multiple clinical trials and through her work as an advocate for greater MBC research. &nbsp;Less than 7% of people diagnosed with cancer participate in clinical trials and less than 5% of breast cancer research funding goes towards metastatic research despite the fact that metastatic breast cancer is incurable and lethal for 99% of patients. Your gift will go towards the research being done in the Labs of Dr. David Shapiro and Dr. Paul Hergenrother of a combination of two therapies called EsRO-TFPy and NK-92 immune cells which are showing astonishing promise in eliminating multiple types of metastatic breast cancers. &nbsp; These therapies may prove more powerful in combination than either one separately and this research could accelerate their movement into clinical trials.&nbsp; Olivia was a cherished friend and member of our community. She will be profoundly missed. Thank you for your gift in honor of Olivia.

Hello <span contenteditable="false" data-custom-variable="{{firstname}}" fr-original-class="fr-deletable styled-tag-chip" fr-original-style="" style="background-color: rgb(248, 248, 255); border: 1px solid rgb(191, 191, 255); border-radius: 4px; color: rgb(42, 42, 196); padding: 1px 8px; font-size: 11px; display: inline-block; margin: 0px; overflow-wrap: anywhere; user-select: none; box-sizing: inherit;">First name, Thank you for your gift in honor of Olivia. 100% of your gift will go directly towards the research of the lab of Dr. David Shapiro and Dr. Paul Hergenrother at University of Illinois who have licensed thei very promising new compound, ErSO-TFPy for the treatment of metastatic breast cancer to Oncoteq. Recent evidence from their lab has indicated that ErSO-TFPy, in combination with NK-92 cells may prove even more effective in eliminating cancer cells. We will keep you updated on the contributions your gift had towards this very promising combination. If you would like to contribute by becoming a volunteer, or to learn more about our research fundraising, please send us an email. In loving memory of Olivia, Carolyn LeighPresidentNorth Star Cancer Research Foundationnscrfoundation@yahoo.com

Olivia was deeply committed to advancing research for metastatic breast cancer (MBC) both through her own participation in multiple clinical trials and through her work as an advocate for greater MBC research.  Less than 7% of people diagnosed with cancer participate in clinical trials and less than 5% of breast cancer research funding goes towards metastatic research despite the fact that metastatic breast cancer is incurable and lethal for 99% of patients. Your gift will go towards the research being done in the Labs of Dr. David Shapiro and Dr. Paul Hergenrother of a combination of two therapies called EsRO-TFPy and NK-92 immune cells which are showing astonishing promise in eliminating multiple types of metastatic breast cancers.   These therapies may prove more powerful in combination than either one separately and this research could accelerate their movement into clinical trials.  Olivia was a cherished friend and member of our community. She will be profoundly missed. Thank you for your gift in honor of Olivia.

In Memory and Honor of Olivia

IsFundraiserFormEditDisabled

IsPaymentByPadAllowed

North Star Cancer Research Foundation

### Context Profile for North Star Cancer Research Foundation

1. **Organization Mission & Cause**:
   - **Mission**: The North Star Cancer Research Foundation is dedicated to advancing research for metastatic breast cancer (MBC), which is currently deemed incurable. Their goal is to fund innovative research, particularly focusing on a promising drug known as TEQ103, which shows potential in treating MBC by killing cancer cells and stimulating the immune system.
   - **Cause**: The foundation aims to transform Breast Cancer Awareness Month into a campaign for MBC cures, raising awareness and funds to support research that could lead to breakthroughs in treatment.

2. **Type of Activities**:
   - **Fundraising Campaigns**: The most recent campaign titled "A Potential Cure For Metastatic Breast Cancer" aims to raise $100,000 by encouraging 1,000 individuals to donate or fundraise $100 each.
   - **Community Engagement**: The foundation organizes Q&A sessions with researchers to discuss ongoing research and findings related to MBC, fostering community involvement and education.
   - **Awareness Initiatives**: They focus on raising awareness about MBC, particularly during Breast Cancer Awareness Month, to highlight its severity and the need for research funding.

3. **Tone of Voice**:
   - The tone is **inspiring** and **urgent**, reflecting a strong call to action for community support. The language is accessible yet informative, aiming to engage readers emotionally and motivate them to contribute to the cause. Phrases like "Let’s end Metastatic Breast Cancer TOGETHER!" exemplify this tone.

4. **Emoji Usage**:
   - The website and campaign materials do not prominently feature emojis in their communications. The tone remains professional and serious, focusing on the gravity of the cause rather than casual or playful elements.

5. **Key Facts**:
   - **Founding Info**: Specific founding details are not provided on the website.
   - **Scale**: The organization has conducted at least three fundraising forms, indicating active engagement in fundraising efforts.
   - **Impact Metrics**: The current campaign aims to raise $100,000, highlighting the foundation's commitment to impactful research funding.
   - **Volunteer Info**: No specific volunteer information is available on the website, but community involvement is encouraged through fundraising and participation in events.

6. **Writing Guidelines**:
   - **Style**: Use clear, direct language that conveys urgency and hope. Avoid overly technical jargon unless necessary, as the audience may not be familiar with scientific terms.
   - **Call to Action**: Include strong calls to action, encouraging donations and community participation. Phrases that inspire collective effort and urgency should be prioritized.
   - **Emotional Engagement**: Use storytelling elements to connect with the audience on an emotional level, particularly regarding the impact of MBC on individuals and families.
   - **Consistency**: Maintain a consistent tone that reflects the seriousness of the cause while also inspiring hope and action.

This context profile serves as a comprehensive guide for generating personalized content that aligns with the North Star Cancer Research Foundation's mission, activities, and communication style.

Would you like to receive updates about the research your gift is helping to fund?

North Star Cancer Research Foundation

In Memory and Honor of Olivia

You'll receive a tax receipt for making a donation.